Dosimetric Outcomes of Definitive Radiation Therapy to Anal Squamous Cell Carcinoma in a Single Institution Using Volumetric Modulated Arc Therapy Evaluated Against Australian and International Treatment Planning Guidelines
Journal of Medical Radiation Sciences · 29.10.2026
DOI: 10.1002/jmrs.70124 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Medical Radiation Sciences, online erschienen am 29.10.2026. Verfasst von Faisal Alshamrani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mid North Coast Cancer Institute, Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Volumetric Modulated Arc Therapy (VMAT) is the technique of choice for anal Squamous Cell Carcinoma (SCC), offering highly conformal dosimetry while improving dose sparing to Organs at Risk (OARs). Achieving the dose constraints listed in national and international guidelines can be challenging. This report validates the achievability of these constraints and brings a clinical context to these guidelines.
Methods
A retrospective analysis of 43 clinician approved plans was conducted. These plans were evaluated against the Radiation Therapy Oncology Workgroup (RTOG) 0529, eviQ, the Assessment of New Radiation Oncology Treatments and Technologies (ANROTAT) and departmental protocol. A constraint was considered ‘pass’ if it met an ideal objective or minor violation. A constraint was considered ‘failed’ if a major violation occurred.
Results
RTOG 0529 Planning Target Volumes (PTV) constraints D98 ≥ 80% and D95 ≥ 90% of the Total Dose (TD) were achieved in 100% of our patient cohort, with a median of 93.8% and 96% TD for the high‐risk PTV (54Gy) and 92.6% and 95.2% TD for the low‐risk PTV (45Gy). The stricter ANROTAT D98 ≥ 90% TD was achieved in 93% of our patient cohort for the high‐risk PTV (54Gy) and 77% for the low‐risk PTV (45Gy). Major violations of the gastrointestinal (GI) OAR constraints were observed in up to 40% of the plans. While there were no strict major violation specifications for skeletal and genitourinary (GU) OARs, dose constraint non‐compliance occurred in up to 19% and 56% of the plans respectively.
Conclusions
Although VMAT is the gold standard for anal SCC, achieving the recommended dose constraints was challenging. Further refinement of dose constraints is essential to ensure the clinical achievability of planning objectives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Mid North Coast Cancer Institute, Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia.
- RCS Faculty of Medicine, University of New South Wales, Coffs Harbour, New South Wales, Australia.
ORCID-Profile: Faisal Alshamrani, Michael Hsieh, Anthony Karl, Stuart Greenham, Maree Wood, Tue Le
Zitieren
APA
Alshamrani, F., Hsieh, M., Karl, A., Chamberlain, L., Greenham, S., Goodworth, J., Wood, M., Shakespeare, T., Le, T., & Tahir, A. M. (2026). Dosimetric Outcomes of Definitive Radiation Therapy to Anal Squamous Cell Carcinoma in a Single Institution Using Volumetric Modulated Arc Therapy Evaluated Against Australian and International Treatment Planning Guidelines. Journal of Medical Radiation Sciences. https://doi.org/10.1002/jmrs.70124
Vancouver
Alshamrani F, Hsieh M, Karl A, Chamberlain L, Greenham S, Goodworth J, et al. Dosimetric Outcomes of Definitive Radiation Therapy to Anal Squamous Cell Carcinoma in a Single Institution Using Volumetric Modulated Arc Therapy Evaluated Against Australian and International Treatment Planning Guidelines. Journal of Medical Radiation Sciences. 2026. doi:10.1002/jmrs.70124
BibTeX
@article{Alshamrani2026,
author = {Alshamrani, Faisal and Hsieh, Michael and Karl, Anthony and Chamberlain, Lauren and Greenham, Stuart and Goodworth, Josie and Wood, Maree and Shakespeare, Thomas and Le, Tue and Tahir, Abdul Mohd},
title = {Dosimetric Outcomes of Definitive Radiation Therapy to Anal Squamous Cell Carcinoma in a Single Institution Using Volumetric Modulated Arc Therapy Evaluated Against Australian and International Treatment Planning Guidelines},
journal = {Journal of Medical Radiation Sciences},
year = {2026},
doi = {10.1002/jmrs.70124}
}
EUVIMED